Abstract

Hepatocellular carcinoma (HCC) is one of the most common malignancies. Current radiological examination is quite limited in diagnosing early HCC. Various treatments for HCC have definite indications, and there is still no effective treatment and prevention for recurrence and metastasis. Based on the recent development of molecular targeting nanotechnology for specific molecules in liver cancer cells, early diagnosis and the monitoring of recurrence and metastasis for HCC can be improved, and the specificity of drug in targeting cancer cells and the therapeutic effect on HCC can be significantly enhanced. The article reviewed the application and significance of molecular targeting nanotechnology in HCC diagnosis and treatment. Key words: Hepatocellular carcinoma; Molecular targets; Nanotechnology; Early diagnosis; Target therapy

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call